A number of firms have modified their ratings and price targets on shares of Fresenius Medical Care AG & Co. KGaA (ETR: FME) recently:

  • 3/9/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €90.00 ($111.11) price target on by analysts at Barclays PLC. They now have a “neutral” rating on the stock.
  • 3/8/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €82.00 ($101.23) price target on by analysts at Commerzbank Ag. They now have a “neutral” rating on the stock.
  • 3/5/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €101.00 ($124.69) price target on by analysts at Berenberg Bank. They now have a “buy” rating on the stock.
  • 2/28/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €92.00 ($113.58) price target on by analysts at Independent Research GmbH. They now have a “neutral” rating on the stock.
  • 2/28/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €102.00 ($125.93) price target on by analysts at Nord/LB. They now have a “buy” rating on the stock.
  • 2/28/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €97.00 ($119.75) price target on by analysts at Cfra. They now have a “buy” rating on the stock.
  • 2/28/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €95.00 ($117.28) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.
  • 2/28/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €96.00 ($118.52) price target on by analysts at Credit Suisse Group AG. They now have a “buy” rating on the stock.
  • 2/27/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €87.00 ($107.41) price target on by analysts at UBS Group AG. They now have a “neutral” rating on the stock.
  • 2/27/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €87.00 ($107.41) price target on by analysts at Commerzbank Ag. They now have a “neutral” rating on the stock.
  • 2/27/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €101.00 ($124.69) price target on by analysts at Berenberg Bank. They now have a “buy” rating on the stock.
  • 2/27/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €95.60 ($118.02) price target on by analysts at JPMorgan Chase & Co.. They now have a “buy” rating on the stock.
  • 2/27/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €97.00 ($119.75) price target on by analysts at Goldman Sachs Group Inc. They now have a “buy” rating on the stock.
  • 2/22/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €92.00 ($113.58) price target on by analysts at Credit Suisse Group AG. They now have a “buy” rating on the stock.
  • 2/19/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €97.00 ($119.75) price target on by analysts at Goldman Sachs Group Inc. They now have a “buy” rating on the stock.
  • 2/16/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €87.00 ($107.41) price target on by analysts at Commerzbank Ag. They now have a “neutral” rating on the stock.
  • 2/13/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €101.00 ($124.69) price target on by analysts at Berenberg Bank. They now have a “buy” rating on the stock.
  • 2/12/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €92.00 ($113.58) price target on by analysts at Citigroup Inc. They now have a “buy” rating on the stock.
  • 2/2/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €90.00 ($111.11) price target on by analysts at Barclays PLC. They now have a “neutral” rating on the stock.
  • 1/31/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €107.00 ($132.10) price target on by analysts at DZ Bank AG. They now have a “buy” rating on the stock.
  • 1/22/2018 – Fresenius Medical Care AG & Co. KGaA was given a new €83.00 ($102.47) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.

Shares of Fresenius Medical Care AG & Co. KGaA (FME) opened at €82.24 ($101.53) on Thursday. Fresenius Medical Care AG & Co. KGaA has a fifty-two week low of €75.53 ($93.25) and a fifty-two week high of €93.82 ($115.83). The stock has a market capitalization of $25,340.00 and a price-to-earnings ratio of 19.67.

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Receive News & Ratings for Fresenius Medical Care AG & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.